| Literature DB >> 34938866 |
Wan Nur Anis Wan Draman1, Mohd Khairi Md Daud1,2, Hazama Mohamad1, Siti Asma Hassan3, Normastura Abd Rahman4.
Abstract
OBJECTIVE: To determine the current microbiological profile of chronic suppurative otitis media (CSOM), their antimicrobial sensitivity, their resistance pattern to locally available antibiotics and the appropriate antibiotic against isolated microorganisms causing CSOM.Entities:
Keywords: antibiotic sensitivity; bacterial profile; chronic suppurative otitis media
Year: 2021 PMID: 34938866 PMCID: PMC8665472 DOI: 10.1002/lio2.682
Source DB: PubMed Journal: Laryngoscope Investig Otolaryngol ISSN: 2378-8038
Sociodemographic profiles of the study participants (n = 88)
| Characteristic | Number of patients (%) |
|---|---|
|
| |
| Male | 30 (34.1) |
| Female | 58 (65.9) |
|
| |
| 1‐10 | 29 (33.0) |
| 11‐20 | 13 (13.6) |
| 21‐40 | 16 (18.2) |
| >41 | 31 (35.1) |
|
| 24.00 (IQR = 41) |
|
| |
| <6 | 20 (22.7) |
| 6‐12 | 23 (26.1) |
| >12 months | 45 (51.1) |
|
| |
| Unilateral | 85 (96.6) |
| Right | 43 (48.9) |
| Left | 42 (47.7) |
| Bilateral | 3 (3.4) |
|
| |
| Upper respiratory tract infection | 49 (55.7) |
| Allergic rhinitis | 24 (27.3) |
| Nil | 15 (17.0) |
|
| |
| Hearing loss | 40 (45.5) |
| Pain | 9 (10.2) |
| Itchiness | 12 (13.6) |
| Nil |
27 (30.7) |
Abbreviation: CSOM: chronic suppurative otitis media.
Characteristics of chronic suppurative otitis media (CSOM) among the study participants (n = 91)
| Characteristic of discharge | No. of ear swabs (%) |
|---|---|
|
| |
| Mucoid | 9 (9.9) |
| Mucopurulent | 44 (48.4) |
| Purulent | 38 (41.8) |
| Blood stained | Nil |
|
| |
| Foul smelling | 2 (2.2) |
| Nonfoul smelling | 89 (97.8) |
|
| |
| <25 | 46 (50.5) |
| 26‐50 | 35 (38.5) |
| 51‐75 | 7 (7.7) |
| >75 (subtotal) | 3 (3.3) |
|
| |
| Marginal | 2 (2.2) |
| Central | 89 (97.8) |
| Attic | Nil |
|
| |
| Yes | 8 (8.8) |
| No | 83 (91.2) |
Microbiological profiles of chronic suppurative otitis media participants (n = 91)
| Type of isolated microorganisms | Frequency (%) | |
|---|---|---|
| Monomicrobial | 63 (69.2) | |
| Polymicrobial | 13 (14.3) | |
| Mixed growth | 9 (9.9) | |
|
No growth |
6 (6.6) | |
| Name of isolated microorganisms | No. of isolates (%) | |
|
Gram‐positive bacteria |
|
15 (16.9) |
|
| 3 (3.4) | |
|
| 1 (1.1) | |
|
Gram‐negative bacteria |
|
29 (32.6) |
|
| 5 (5.6) | |
|
| 4 (4.5) | |
|
| 4 (4.5) | |
|
| 4 (4.5) | |
|
| 3 (3.4) | |
|
| 2 (2.2) | |
|
| 3 (3.4) | |
|
| 2 (2.2) | |
|
| 1 (1.1) | |
|
|
1 (1.1) | |
|
Fungal organisms |
|
7 (7.9) |
|
| 4 (4.5) | |
|
|
1 (1.1) | |
Distribution of isolated microorganisms among different age groups (n = 64)
| Age, years | Gram‐positive microorganisms n (%) | Gram‐negative microorganisms n (%) |
|
|---|---|---|---|
| 0‐10 | 3 (14.3) | 18 (85.7) | .025 |
| 11‐20 | 6 (54.5) | 5 (45.5) | |
| 21‐40 | 4 (33.3) | 8 (66.7) |
.573 |
| >41 | 6 (30.0) | 14 (70.0) |
Fisher's exact test was applied.
Antibiotic sensitivity pattern of gram‐positive microorganisms (n = 18)
| Antibiotic |
|
|
|---|---|---|
| Trimethoprim‐sulfamethoxazole | 12 (80.0) | 1 (33.3) |
| Clindamycin | 12 (80.0) | 3 (100) |
| Erythromycin | 12 (80.0) | 3 (100) |
| Chloramphenicol | 12 (80.0) | 3 (100) |
| Fusidic acid | 14 (93.3) | — |
| Penicillin G | 2 (13.3) | 3 (100) |
| Gentamicin | 12 (80.0) | — |
| Rifampin | 15 (100) | — |
| Cefoxitin | 14 (93.3) | — |
| Ciprofloxacin | 10 (66.7) | — |
| Cephalexin | — | 3 (100) |
| Chloramphenicol | — | 2 (66.7) |
| Tetracycline | — | 1 (33.3) |
Antibiotic sensitivity patterns of gram‐negative microorganisms (n = 48)
| Antibiotic |
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| Amikacin | 23 (79.3) | 5 (100) | 4 (100) | 4 (100) | 3 (100) | 3 (100) |
| Ceftriaxone | — | 4 (80.0) | — | 4 (100) | 3 (100) | 3 (100) |
| Cefuroxime | — | 4 (80.0) | — | 4 (100) | 3 (100) | 1 (33.3) |
| Ceftazidime | 29 (100) | 4 (80.0) | 4 (100) | 4 (100) | 3 (100) | 3 (100) |
| Cefotaxime | — | 4 (80.0) | — | 4 (100) | 3 (100) | 3 (100) |
| Imipenem | 28 (96.6) | 5 (100) | 3 (75.0) | 4 (100) | 3(100) | 3 (100) |
| Meropenem | 29 (100) | — | 3 (75.0) | — | — | — |
| Ciprofloxacin | 27 (93.1) | 4 (80.0) | 3 (75.0) | 3 (75.0) | 3 (100) | 3 (100) |
| Piperacillin‐tazobactam | 29 (100) | 5 (100) | 4 (100) | 4 (100) | 3 (100) | 2 (66.7) |
| Cefepime | 29 (100) | 4 (80.0) | — | 4 (100) | 3 (100) | 3 (100) |
| Gentamicin | 25 (86.2) | 5 (100) | 4 (100) | 4 (100) | 2 (66.7) | 3 (100) |
| Chloramphenicol | — | 5 (100) | — | 1 (25.0) | 2 (66.7) | 2 (66.7) |
| Amoxillin clavulanate | — | 4 (80.0) | — | 3 (75.0) | 3 (100) | 1 (33.3) |
| Ampicillin | — | 0 (0) | 4 (100) | 1 (25.0) | 1 (33.3) | 1 (33.3) |
| Trimethoprim‐sulfamethazole | — | 4 (80.0) | — | 1 (25.0) | 2 (66.7) | 3 (100) |